iTeos Therapeutics Inc. (ITOS) Social Stream
ITEOS THERAPEUTICS INC (ITOS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ITOS.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-26 | 5 | $55 | $37 | $49.2 | $10.7 | 359.81% |
| 2021-11-11 | 5 | $55 | $37 | $48.4 | $10.7 | 352.34% |
| 2021-11-26 | 5 | $54 | $37 | $46.6 | $10.7 | 335.51% |
| 2021-12-13 | 5 | $54 | $42 | $50 | $10.7 | 367.29% |
| 2021-12-16 | 5 | $54 | $42 | $49.75 | $10.7 | 364.95% |
| 2022-03-24 | 5 | $54 | $42 | $50.2 | $10.7 | 369.16% |
| 2022-05-09 | 5 | $60 | $42 | $51.4 | $10.7 | 380.37% |
| 2022-05-12 | 5 | $60 | $34 | $49.8 | $10.7 | 365.42% |
| 2022-05-13 | 5 | $60 | $34 | $44.8 | $10.7 | 318.69% |
| 2022-08-10 | 5 | $59 | $34 | $44.6 | $10.7 | 316.82% |
| 2022-08-22 | 5 | $59 | $34 | $45.2 | $10.7 | 322.43% |
| 2022-11-14 | 5 | $54 | $34 | $44.2 | $10.7 | 313.08% |
| 2023-03-17 | 5 | $54 | $32 | $41.4 | $10.7 | 286.92% |
| 2023-03-27 | 5 | $54 | $32.001 | $41.4 | $10.7 | 286.92% |
| 2023-05-11 | 5 | $54 | $32.001 | $40.2 | $10.7 | 275.7% |
| 2023-08-08 | 5 | $54 | $32 | $40.2 | $10.7 | 275.7% |
| 2023-08-11 | 5 | $48 | $32 | $38.2 | $10.7 | 257.01% |
| 2023-11-08 | 5 | $47 | $32 | $38 | $10.7 | 255.14% |
| 2023-11-13 | 5 | $47 | $29 | $37.4 | $10.7 | 249.53% |
The Trend in the Analyst Price Target
Over the past 37 months, ITOS's average price target has gone down $6.
Over the past 34 weeks, ITOS's average upside potential has been 214.69%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-17 | 5 | 54 | 32.000 | 41.40 | 14.12 | 193.2% |
| 2023-03-17 | 5 | 54 | 33.000 | 43.75 | 14.12 | 209.84% |
| 2023-05-11 | 5 | 54 | 32.001 | 40.20 | 14.07 | 185.71% |
| 2023-11-08 | 5 | 47 | 32.000 | 38.00 | 9.89 | 284.23% |
| 2023-11-13 | 5 | 47 | 29.000 | 37.40 | 9.60 | 289.58% |
ITOS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 5 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 26 weeks, ITOS's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, ITEOS THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 2003.19% of them.
- In the context of all US stocks, ITEOS THERAPEUTICS INC's number of analysts covering the stock is greater than 446.6% of them.
- ITOS has a greater average analyst price target than 1930.43% of stocks in the small market cap category.
- ITEOS THERAPEUTICS INC's variance in analysts' estimates is lower than -534.08% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ITEOS THERAPEUTICS INC are MTEX, PROC, and COLL.
View All Top Stocks by Price Target
Make investment decisions regarding ITOS using the data that counts. Try POWR Ratings for free.